Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smoking.

Michael Miller,Deepak L Bhatt,Ph Gabriel Steg,Eliot A Brinton,Terry A Jacobson,Lixia Jiao,Jean-Claude Tardif,Christie M Ballantyne,Matthew Budoff,R Preston Mason

European heart journal. Cardiovascular pharmacotherapy（2023）

引用 7|浏览23

暂无评分

摘要

In REDUCE-IT, IPE treatment was associated with a reduced risk of CV events in current and former smokers to levels observed in never smokers. While smoking cessation should always be recommended, these data raise the possibility that IPE treatment may attenuate CV hazards attributable to smoking.

查看译文

关键词

Cigarette smoking,Clinical trial,Hypertriglyceridemia,Icosapent ethyl,Reduce-IT

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要